The U.S. irradiation apparatus market is projected to grow from an estimated USD 2.88 billion in 2024 to a CAGR of 6% between 2025 and 2030, driven by rising demand for non-invasive medical procedures and the increasing incidence of chronic diseases such as cancer. Notably, lung cancer cases in the U.S. are expected to exceed 234,580 in 2024, highlighting a shift towards non-invasive diagnostic solutions. Innovations in radiation therapies, like hypo-fractionated radiotherapy, and the recent launch of the NetDose PRO radiation dosimeter by Thermo Fisher Scientific, underline advancements in safety and treatment precision in the sector. The report provides comprehensive forecasts and analyses of market trends through 2030.
Tue, 21 Jan 2025 13:36:11 GMT | GlobeNewswire